GeneTether Therapeutics Inc.
Other OTCShare Statistics
GeneTether Therapeutics Inc. currently has 38.74M shares outstanding.
| Shares Outstanding | 38.74M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
GeneTether Therapeutics Inc. maintains a current ratio of 47.55, meaning it holds 47.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 47.55 |
| Quick Ratio | 47.55 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -127.65 |
| Return on Assets (ROA) | -44.48 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
GeneTether Therapeutics Inc.'s stock has declined approximately -94.73684% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | -94.73684% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -658,516.00, while operating income came in at -658,516.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -658,516.00 |
| Pretax Income | -595,808.00 |
| Net Income | -595,808.00 |
| EBITDA | -658,516.00 |
| EBIT | -658,516.00 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Total book value stands at -337,763.00, with working capital of 1.08M providing operational flexibility.
| Cash & Cash Equivalents | 1.03M |
| Total Debt | N/A |
| Net Debt | -1.03M |
| Equity (Book Value) | -337,763.00 |
| Book Value Per Share | -0.01 |
| Working Capital | 1.08M |
Cash Flow
GeneTether Therapeutics Inc. produced -356,320.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -356,320.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -356,320.00 |
| FCF Per Share | -0.01 |
Scores
GeneTether Therapeutics Inc. posts an Altman Z-Score of -6.54, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -6.54 |